Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Jan;48(1):1–6. doi: 10.1136/jcp.48.1.1

Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.

C S Herrington 1
PMCID: PMC502251  PMID: 7706512

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barton S. E., Hollingworth A., Maddox P. H., Edwards R., Cuzick J., McCance D. J., Jenkins D., Singer A. Possible cofactors in the etiology of cervical intraepithelial neoplasia. An immunopathologic study. J Reprod Med. 1989 Sep;34(9):613–616. [PubMed] [Google Scholar]
  2. Bosch F. X., Schwarz E., Boukamp P., Fusenig N. E., Bartsch D., zur Hausen H. Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells. J Virol. 1990 Oct;64(10):4743–4754. doi: 10.1128/jvi.64.10.4743-4754.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braun L., Dürst M., Mikumo R., Crowley A., Robinson M. Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection. Mol Carcinog. 1992;6(2):100–111. doi: 10.1002/mc.2940060205. [DOI] [PubMed] [Google Scholar]
  4. Burger M. P., Hollema H., Gouw A. S., Pieters W. J., Quint W. G. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ. 1993 Mar 20;306(6880):749–752. doi: 10.1136/bmj.306.6880.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen M., Popescu N., Woodworth C., Berneman Z., Corbellino M., Lusso P., Ablashi D. V., DiPaolo J. A. Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol. 1994 Feb;68(2):1173–1178. doi: 10.1128/jvi.68.2.1173-1178.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen T. M., Defendi V. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Oncogene. 1992 Aug;7(8):1541–1547. [PubMed] [Google Scholar]
  7. Crook T., Morgenstern J. P., Crawford L., Banks L. Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J. 1989 Feb;8(2):513–519. doi: 10.1002/j.1460-2075.1989.tb03405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crook T., Storey A., Almond N., Osborn K., Crawford L. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci U S A. 1988 Dec;85(23):8820–8824. doi: 10.1073/pnas.85.23.8820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crook T., Vousden K. H. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J. 1992 Nov;11(11):3935–3940. doi: 10.1002/j.1460-2075.1992.tb05487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Crook T., Wrede D., Vousden K. H. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene. 1991 May;6(5):873–875. [PubMed] [Google Scholar]
  11. Davies R., Hicks R., Crook T., Morris J., Vousden K. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol. 1993 May;67(5):2521–2528. doi: 10.1128/jvi.67.5.2521-2528.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. De Marco F., Marcante M. L. HPV-16 E6-E7 differential transcription induced in Siha cervical cancer cell line by interferons. J Biol Regul Homeost Agents. 1993 Jan-Mar;7(1):15–21. [PubMed] [Google Scholar]
  13. Dhanwada K. R., Garrett L., Smith P., Thompson K. D., Doster A., Jones C. Characterization of human keratinocytes transformed by high risk human papillomavirus types 16 or 18 and herpes simplex virus type 2. J Gen Virol. 1993 Jun;74(Pt 6):955–963. doi: 10.1099/0022-1317-74-6-955. [DOI] [PubMed] [Google Scholar]
  14. Di Luca D., Costa S., Monini P., Rotola A., Terzano P., Savioli A., Grigioni W., Cassai E. Search for human papillomavirus, herpes simplex virus and c-myc oncogene in human genital tumors. Int J Cancer. 1989 Apr 15;43(4):570–577. doi: 10.1002/ijc.2910430407. [DOI] [PubMed] [Google Scholar]
  15. DiPaolo J. A., Popescu N. C., Alvarez L., Woodworth C. D. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. Crit Rev Oncog. 1993;4(4):337–360. [PubMed] [Google Scholar]
  16. Dyson N., Howley P. M., Münger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989 Feb 17;243(4893):934–937. doi: 10.1126/science.2537532. [DOI] [PubMed] [Google Scholar]
  17. Falcinelli C., Luzi P., Alberti P., Cosmi E. V., Anceschi M. M. Human papilloma virus infection and Ki-ras oncogene in paraffin-embedded squamous carcinomas of the cervix. Gynecol Obstet Invest. 1993;36(3):185–188. doi: 10.1159/000292623. [DOI] [PubMed] [Google Scholar]
  18. Glew S. S., Duggan-Keen M., Ghosh A. K., Ivinson A., Sinnott P., Davidson J., Dyer P. A., Stern P. L. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol. 1993 Jul;37(3):157–164. doi: 10.1016/0198-8859(93)90181-y. [DOI] [PubMed] [Google Scholar]
  19. Gloss B., Bernard H. U., Seedorf K., Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 1987 Dec 1;6(12):3735–3743. doi: 10.1002/j.1460-2075.1987.tb02708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gu Z., Pim D., Labrecque S., Banks L., Matlashewski G. DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6. Oncogene. 1994 Feb;9(2):629–633. [PubMed] [Google Scholar]
  21. Herrero R., Brinton L. A., Reeves W. C., Brenes M. M., Tenorio F., de Britton R. C., Gaitan E., Garcia M., Rawls W. E. Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst. 1989 Feb 1;81(3):205–211. doi: 10.1093/jnci/81.3.205. [DOI] [PubMed] [Google Scholar]
  22. Hilders C. G., Houbiers J. G., van Ravenswaay Claasen H. H., Veldhuizen R. W., Fleuren G. J. Association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab Invest. 1993 Dec;69(6):651–659. [PubMed] [Google Scholar]
  23. Hoppe-Seyler F., Butz K. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J Virol. 1993 Jun;67(6):3111–3117. doi: 10.1128/jvi.67.6.3111-3117.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hubbert N. L., Sedman S. A., Schiller J. T. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol. 1992 Oct;66(10):6237–6241. doi: 10.1128/jvi.66.10.6237-6241.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Iwasaka T., Yokoyama M., Oh-uchida M., Matsuo N., Hara K., Fukuyama K., Hachisuga T., Fukuda K., Sugimori H. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas. Gynecol Oncol. 1992 Sep;46(3):298–303. doi: 10.1016/0090-8258(92)90220-d. [DOI] [PubMed] [Google Scholar]
  26. Johnson J. C., Burnett A. F., Willet G. D., Young M. A., Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol. 1992 Mar;79(3):321–327. doi: 10.1097/00006250-199203000-00001. [DOI] [PubMed] [Google Scholar]
  27. Kessis T. D., Slebos R. J., Nelson W. G., Kastan M. B., Plunkett B. S., Han S. M., Lorincz A. T., Hedrick L., Cho K. R. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988–3992. doi: 10.1073/pnas.90.9.3988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Landers R. J., O'Leary J. J., Crowley M., Healy I., Annis P., Burke L., O'Brien D., Hogan J., Kealy W. F., Lewis F. A. Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix. J Clin Pathol. 1993 Oct;46(10):931–935. doi: 10.1136/jcp.46.10.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lane S., Wells M. Human papillomaviruses, p53, and cervical neoplasia. J Pathol. 1994 Apr;172(4):299–300. doi: 10.1002/path.1711720402. [DOI] [PubMed] [Google Scholar]
  30. Liang X. H., Volkmann M., Klein R., Herman B., Lockett S. J. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene. 1993 Oct;8(10):2645–2652. [PubMed] [Google Scholar]
  31. Lippman S. M., Kavanagh J. J., Paredes-Espinoza M., Delgadillo-Madrueño F., Paredes-Casillas P., Hong W. K., Holdener E., Krakoff I. H. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst. 1992 Feb 19;84(4):241–245. doi: 10.1093/jnci/84.4.241. [DOI] [PubMed] [Google Scholar]
  32. Matlashewski G., Osborn K., Banks L., Stanley M., Crawford L. Transformation of primary human fibroblast cells with human papillomavirus type 16 DNA and EJ-ras. Int J Cancer. 1988 Aug 15;42(2):232–238. doi: 10.1002/ijc.2910420215. [DOI] [PubMed] [Google Scholar]
  33. Mehal W. Z., Lo Y. M., Herrington C. S., Evans M. F., Papadopoulos M. C., Odunis K., Ganesan T. S., McGee J. O., Bell J. I., Fleming K. A. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol. 1994 Dec;47(12):1077–1081. doi: 10.1136/jcp.47.12.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mitrani-Rosenbaum S., Tsvieli R., Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol. 1989 Aug;70(Pt 8):2227–2232. doi: 10.1099/0022-1317-70-8-2227. [DOI] [PubMed] [Google Scholar]
  35. Morelli A. E., Sananes C., Di Paola G., Paredes A., Fainboim L. Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Pathol. 1993 Feb;99(2):200–206. doi: 10.1093/ajcp/99.2.200. [DOI] [PubMed] [Google Scholar]
  36. Morris H. H., Gatter K. C., Sykes G., Casemore V., Mason D. Y. Langerhans' cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br J Obstet Gynaecol. 1983 May;90(5):412–420. doi: 10.1111/j.1471-0528.1983.tb08936.x. [DOI] [PubMed] [Google Scholar]
  37. Paquette R. L., Lee Y. Y., Wilczynski S. P., Karmakar A., Kizaki M., Miller C. W., Koeffler H. P. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer. 1993 Aug 15;72(4):1272–1280. doi: 10.1002/1097-0142(19930815)72:4<1272::aid-cncr2820720420>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  38. Park D. J., Wilczynski S. P., Paquette R. L., Miller C. W., Koeffler H. P. p53 mutations in HPV-negative cervical carcinoma. Oncogene. 1994 Jan;9(1):205–210. [PubMed] [Google Scholar]
  39. Pater A., Bayatpour M., Pater M. M. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol. 1990 Apr;162(4):1099–1103. doi: 10.1016/0002-9378(90)91323-5. [DOI] [PubMed] [Google Scholar]
  40. Phelps W. C., Howley P. M. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J Virol. 1987 May;61(5):1630–1638. doi: 10.1128/jvi.61.5.1630-1638.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rando R. F., Lindheim S., Hasty L., Sedlacek T. V., Woodland M., Eder C. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol. 1989 Jul;161(1):50–55. doi: 10.1016/0002-9378(89)90231-7. [DOI] [PubMed] [Google Scholar]
  42. Riou G., Barrois M., Sheng Z. M., Duvillard P., Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene. 1988 Sep;3(3):329–333. [PubMed] [Google Scholar]
  43. Riou G., Lê M. G., Favre M., Jeannel D., Bourhis J., Orth G. Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers. J Natl Cancer Inst. 1992 Oct 7;84(19):1525–1526. doi: 10.1093/jnci/84.19.1525. [DOI] [PubMed] [Google Scholar]
  44. Scheffner M., Huibregtse J. M., Vierstra R. D., Howley P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993 Nov 5;75(3):495–505. doi: 10.1016/0092-8674(93)90384-3. [DOI] [PubMed] [Google Scholar]
  45. Schneider V., Kay S., Lee H. M. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol. 1983 May-Jun;27(3):220–224. [PubMed] [Google Scholar]
  46. Sedman S. A., Hubbert N. L., Vass W. C., Lowy D. R., Schiller J. T. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity. J Virol. 1992 Jul;66(7):4201–4208. doi: 10.1128/jvi.66.7.4201-4208.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Simons A. M., Phillips D. H., Coleman D. V. Damage to DNA in cervical epithelium related to smoking tobacco. BMJ. 1993 May 29;306(6890):1444–1448. doi: 10.1136/bmj.306.6890.1444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Spinillo A., Tenti P., Zappatore R., De Seta F., Silini E., Guaschino S. Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. Gynecol Oncol. 1993 Feb;48(2):210–213. doi: 10.1006/gyno.1993.1035. [DOI] [PubMed] [Google Scholar]
  49. Steinmann K. E., Pei X. F., Stöppler H., Schlegel R., Schlegel R. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes. Oncogene. 1994 Feb;9(2):387–394. [PubMed] [Google Scholar]
  50. Storey A., Almond N., Osborn K., Crawford L. Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein. J Gen Virol. 1990 Apr;71(Pt 4):965–970. doi: 10.1099/0022-1317-71-4-965. [DOI] [PubMed] [Google Scholar]
  51. Storey A., Pim D., Murray A., Osborn K., Banks L., Crawford L. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J. 1988 Jun;7(6):1815–1820. doi: 10.1002/j.1460-2075.1988.tb03013.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Teyssier J. R. The chromosomal analysis of human solid tumors. A triple challenge. Cancer Genet Cytogenet. 1989 Jan;37(1):103–125. doi: 10.1016/0165-4608(89)90080-0. [DOI] [PubMed] [Google Scholar]
  53. Vernon S. D., Hart C. E., Reeves W. C., Icenogle J. P. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res. 1993 Feb;27(2):133–145. doi: 10.1016/0168-1702(93)90077-z. [DOI] [PubMed] [Google Scholar]
  54. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990 Apr 6;248(4951):76–79. doi: 10.1126/science.2157286. [DOI] [PubMed] [Google Scholar]
  55. Woodworth C. D., Lichti U., Simpson S., Evans C. H., DiPaolo J. A. Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Res. 1992 Jan 15;52(2):456–463. [PubMed] [Google Scholar]
  56. Woodworth C. D., Wang H., Simpson S., Alvarez-Salas L. M., Notario V. Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus-expressing cell lines. Cell Growth Differ. 1993 May;4(5):367–376. [PubMed] [Google Scholar]
  57. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet. 1994 Apr 16;343(8903):955–957. doi: 10.1016/s0140-6736(94)90070-1. [DOI] [PubMed] [Google Scholar]
  58. zur Hausen H. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet. 1986 Aug 30;2(8505):489–491. doi: 10.1016/s0140-6736(86)90360-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES